loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 75502 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE (1)

filter

01 FOUGERA PHARMS (1)

filter

01 CREAM;TOPICAL (1)

filter

01 EQ 0.05% BASE;1% (1)

filter

01 USA (1)

Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
CREAM;TOPICAL
EQ 0.05% BASE;1%
CLOTRIMAZOLE AND BETAM...
USA
75502
2001-06-05
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 75502

Looking for CTD TGA MCC DOSSIER APPLICATION 75502 1

19

Fougera Pharmaceuticals Inc., based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE, with a corresponding application number 75502 and regulatory information .

proudly manufactured in the

approval since 2001-06-05

Fougera Pharmaceuticals Inc.'s CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE CREAM;TOPICAL, medication with EQ 0.05% BASE;1% of BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE.

Post Enquiry
POST ENQUIRY